Dr. Rajesh Sehgal, MD

Dr. Sehgal practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Sehgal's NPI, 1003019571, was assigned on June 11, 2007. Dr. Sehgal graduated from Government Medical College Amritsar in 2000. Dr. Sehgal holds Florida license ME155083.

Dr. Sehgal's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Sehgal's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Sehgal is also affiliated with AdventHealth Daytona Beach. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Sehgal to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sehgal practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sehgal's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Sehgal is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Sehgal's licenses on file in 4 states: Florida, Pennsylvania, West Virginia and Michigan.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), lung cancer, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Sehgal treats.

CMS data shows 2,319 Medicare services from Dr. Sehgal across 9 procedure codes in 2024, for 498 Medicare patients. Medicare paid $135,773 for them.

CMS counts 498 Medicare patients who saw Dr. Sehgal in 2024. The largest group is 75 to 84, with 192 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sehgal's median patient age at 68, with 63% women.

In 2024, Dr. Sehgal wrote 1,268 Medicare Part D claims for 267 patients. 79% of them were for generic drugs. CMS names the drug for 1,095 of them, across 21 drugs with 11 or more claims each, at $1,307,879 in total drug cost. In 2023, CMS named 539 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sehgal for performance year 2024, reported as part of a group. Dr. Sehgal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sehgal as offering telehealth.

Dmand AI links 16 papers to Dr. Sehgal, published from 2009 to 2019. 2013 was the busiest year, with 3. The most frequent topics are Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols and Angiogenesis Inhibitors. Dr. Sehgal's most frequent co-authors are Wassim M. McHayleh, MD, Sheikh Asim Ali, MD and Mounzer E. Agha, MD.

Dmand AI links Dr. Sehgal to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 69 general payments to Dr. Sehgal from 25 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Amgen Inc. paid the most, $21,355.

Dmand AI lists 1 award for Dr. Sehgal, most recently ACP Fellow in 2012.

Dr. Sehgal graduated from Government Medical College Amritsar in 2000. Dr. Sehgal is a member of ACP.

Dr. Sehgal is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.